Martin Shkreli (born April 1, 1983) is an American hedge fund manager and entrepreneur, specializing in healthcare businesses, and is a co-founder of MSMB Capital Management and the founder of Turing Pharmaceuticals AG. He is a co-founder and was the Chief Executive Officer of Retrophin LLC, a biotechnology firm founded in 2011.[1][2] Shkreli came to public attention in September 2015, when Turing Pharmaceuticals obtained the manufacturing licence for Daraprim, an out-of-patent medicine, and raised its price by 5,455 percent (from $13.50 to $750 per tablet).
In September 2015, Shkreli was criticized by several health organizations for obtaining manufacturing licenses on old, out-of-patent, life-saving medicines including pyrimethamine (brand name Daraprim), which is used to treat patients with toxoplasmosis, malaria, some cancers, and AIDS,[16] and then increasing the price of the drug in the US from $13.50 to $750 per pill, a 5,500% increase.[12][17] In an interview with Bloomberg News Shkreli claimed that despite the price increase, that patient co-pays would actually be lower, that many patients would get the drug at no cost, that the company has expanded its free drug program, and that it gives away half of the drugs for only one dollar.[18]
The price increase has been criticized by Hillary Clinton,[16] the HIV Medicine Association,[19] the Infectious Diseases Society of America,[12] the lobbying group Pharmaceutical Research and Manufacturers of America,[20] Donald Trump,[21] and Bernie Sanders.[22]
https://en.wikipedia.org/wiki/Martin_Shkreli#Price_hike_controversy
Reasons to raid:
*ex wall street worker.
*fucking prick who will kill people through unreasonable medicine cost hikes.
*claims he is "albanian" but looks like a jew.
* has a massive case of unwarranted self importance and is a douchebag on twitter.